National Bank of Canada’s Vaxart VXRT Stock Holding History

National Bank of Canada’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,160	Closed	-$1.98M	–	3036
2021 Q4	$1.98M	Buy	+3,160	New	+$21.6K	0.01%	820

Other funds holding VXRT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

National Bank of Canada's VXRT Position: Q1 2025 in Review

National Bank of Canada sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 10,000 shares — an estimated $6.62K sold.

National Bank of Canada first reported a position in VXRT in Q4 2021 and held it in 4 quarters. The position peaked at $1.98M in Q4 2021. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

National Bank of Canada reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
National Bank of Canada sold 10,000 Vaxart shares in Q1 2025, an estimated $6.62K.
National Bank of Canada first reported a position in Vaxart in Q4 2021 and held it in 4 quarters.
National Bank of Canada's Vaxart position peaked at $1.98M in Q4 2021.
92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.